MDWD

Mediwound Ltd

MDWD, USA

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

https://www.mediwound.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MDWD
stock
MDWD

Quarterly Earnings: How MDWD stock reacts to oil prices - 2025 Earnings Surprises & Community Trade Idea Sharing moha.gov.vn

Read more →
MDWD
stock
MDWD

Analysts’ Top Healthcare Picks: Elanco Animal Health (ELAN), Mediwound (MDWD) The Globe and Mail

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$31.5

Analyst Picks

Strong Buy

4

Buy

2

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

4.20

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-5.29 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.81 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-68.21 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Medium

0.70

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 44.20% of the total shares of Mediwound Ltd

1.

Investors Finance Co PLC

(8.0188%)

since

2025/06/30

2.

Yelin Lapidot Holdings Management Ltd

(7.5098%)

since

2025/06/30

3.

BlackRock Inc

(3.9596%)

since

2025/06/30

4.

Rosalind Advisors, Inc.

(3.7429%)

since

2025/06/30

5.

T. Rowe Price Associates, Inc.

(3.4469%)

since

2025/06/30

6.

iShares Russell 2000 ETF

(1.8612%)

since

2025/08/31

8.

Essex Investment Management Company, LLC

(1.3499%)

since

2025/06/30

9.

Northern Trust Corp

(1.2478%)

since

2025/06/30

10.

State Street Corp

(1.0192%)

since

2025/06/30

11.

Geode Capital Management, LLC

(0.9108%)

since

2025/06/30

12.

ARK Israel Innovative Technology ETF

(0.9069%)

since

2025/08/28

13.

ARK Investment Management LLC

(0.8705%)

since

2025/06/30

14.

Fidelity Small Cap Index

(0.715%)

since

2025/06/30

15.

Balyasny Asset Management LLC

(0.6947%)

since

2025/06/30

16.

UBS Group AG

(0.6087%)

since

2025/06/30

17.

iShares Russell 2000 Growth ETF

(0.5952%)

since

2025/08/31

18.

Dafna Capital Management LLC

(0.5929%)

since

2025/06/30

19.

Sargent Investment Group, LLC

(0.4958%)

since

2025/06/30

20.

Vanguard Group Inc

(0.4952%)

since

2025/06/30

21.

Morgan Stanley - Brokerage Accounts

(0.4428%)

since

2025/06/30

22.

Legato Capital Management LLC

(0.3968%)

since

2025/06/30

23.

Millennium Management LLC

(0.354%)

since

2025/06/30

24.

Vanguard Russell 2000 ETF

(0.3375%)

since

2025/07/31

25.

1290 Essex Small Cap Growth I

(0.3065%)

since

2025/07/31

26.

Citadel Advisors Llc

(0.2948%)

since

2025/06/30

27.

Pleiades Small Cap Equity A

(0.1935%)

since

2025/06/30

28.

Schwab Small Cap Index

(0.178%)

since

2025/07/31

29.

NT R2000 Index Fund - NL

(0.1715%)

since

2025/06/30

30.

iShares Micro-Cap ETF

(0.1588%)

since

2025/08/31

31.

NT R2000 Index Fund - DC - NL - 3

(0.1368%)

since

2025/06/30

32.

iShares Russell 2000 Small-Cap Idx Instl

(0.1212%)

since

2025/07/31

33.

Russell 2500™ Index Fund F

(0.1202%)

since

2025/06/30

34.

State St Russell Sm Cap® Indx SL Cl I

(0.1112%)

since

2025/08/31

35.

Nuveen Small Cap Blend Idx R6

(0.0993%)

since

2025/07/31

36.

Russell 2000 Index Non-Lendable Fund E

(0.0898%)

since

2025/06/30

37.

EQ/2000 Managed Volatility IB

(0.0851%)

since

2025/07/31

38.

Russell Personalized DI All Cap SMA

(0.07%)

since

2025/06/30

39.

Spartan Small Cap Index Pool K

(0.0673%)

since

2025/06/30

40.

LVIP SSgA Small Cap Index Std

(0.0653%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.8483

Latest Release

Date

2025-09-30

EPS Actual

-0.24

EPS Estimate

-0.8133

EPS Difference

0.5733

Surprise Percent

70.4906%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(3)
Quality
Low Quality Business(2)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.